medicina61巻7号

2024年06月発行

特集 この1冊でもう安心！—内科医が押さえておきたい「しびれ・ふるえ・めまい」の診かた しびれ，ふるえ，めまいなど多彩な神経症状を呈する疾患の診かた

COVID-19感染によるしびれ，ふるえ，めまい

著者： 大野陽哉¹ 下畑享良¹

所属機関： ¹岐阜大学大学院医学系研究科脳神経内科学分野

ページ範囲：P.1147 - P.1151

Point
◎COVID-19による「しびれ」をきたす疾患として，small fiber neuropathy，Guillain-Barré症候群，脳梗塞などがある．
◎COVID-19による「ふるえ」には，自己免疫性や代謝性，機能性などの病態を背景とする振戦やミオクローヌスがある．
◎COVID-19の「めまい」には，前庭機能障害のほか，感染に伴う全身症状が関与している可能性がある．

参考文献

1）Strand N, et al：Small fiber neuropathy. Curr Pain Headache Rep 26：429-438, 2022 PMID 35384587

2）Burakgazi AZ：Small-fiber neuropathy possibly associated with COVID-19. Case Rep Neurol 14：208-212, 2022 PMID 35702058

3）Shouman K, et al：Autonomic dysfunction following COVID-19 infection；An early experience. Clin Auton Res 31：385-394, 2021 PMID 33860871

4）Abrams RMC, et al：Small fiber neuropathy associated with SARS-CoV-2 infection. Muscle Nerve 65：440-443, 2022 PMID 34766365

5）Oaklander AL, et al：Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol Neuroimmunol Neuroinflamm 9：e1146, 2022 PMID 35232750

6）Gemignani F：Small fiber neuropathy and SARS-CoV-2 infection. Another piece in the long COVID puzzle? Muscle Nerve 65：369-370, 2022 PMID 35014706

7）Shahrizaila N, et al：Guillain-Barré syndrome. Lancet 397：1214-1228, 2021 PMID 33647239

8）Palaiodimou L, et al：Prevalence, clinical characteristics and outcomes of Guillain-Barré syndrome spectrum associated with COVID-19；A systematic review and meta-analysis. Eur J Neurol 28：3517-3529, 2021 PMID 33837630

9）Zheng X, et al：Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barré syndrome? Eur J Med Res 28：98, 2023 PMID 36841799

10）Pimentel V, et al：Guillain-Barré syndrome associated with COVID-19；A systematic review. Brain Behav Immun Health 28：100578, 2023 PMID 36686624

11）Nannoni S, et al：Stroke in COVID-19；A systematic review and meta-analysis. Int J Stroke 16：137-149, 2021 PMID 33103610

12）Luo W, et al：Ischemic stroke associated with COVID-19；A systematic review and meta-analysis. J Neurol 269：1731-1740, 2022 PMID 34652503

13）Murala S, et al：Infectious causes of stroke. J Stroke Cerebrovasc Dis 31：106274, 2022 PMID 35093633

14）Huang C, et al：Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395：497-506, 2020 PMID 31986264

15）Ackermann M, et al：Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 383：120-128, 2020 PMID 32437596

16）Sardu C, et al：Hypertension, thrombosis, kidney failure, and diabetes；Is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. J Clin Med 9：1417, 2020 PMID 32403217

17）Hess DC, et al：COVID-19-related stroke. Transl Stroke Res 11：322-325, 2020 PMID 32378030

18）Akhmerov A, Marbán E：COVID-19 and the heart. Circ Res 126：1443-1455, 2020 PMID 32252591

19）Salari M, et al：Movement disorders associated with COVID-19. Parkinsons Dis 2021：3227753, 2021 PMID 34790346

20）Cuhna P, et al：Movement disorders as a new neurological clinical picture in severe SARS-CoV-2 infection. Eur J Neurol 27：e88-e90, 2020 PMID 32786131

21）Grimaldi S, et al：Autoimmune encephalitis concomitant with SARS-CoV-2 infection；Insight from 18F-FDG PET imaging and neuronal autoantibodies. J Nucl Med 61：1726-1729, 2020 PMID 32709734

22）Anand P, et al：Myoclonus in patients with coronavirus disease 2019；A multicenter case series. Crit Care Med 48：1664-1669, 2020 PMID 32804787

23）Finsterer J：Intensification of an essential tremor by SARS-CoV-2. Cerebellum 22：485-486, 2023 PMID 35499810

24）Makhoul K, Jankovic J：Parkinson's disease after COVID-19. J Neurol Sci 422：117331, 2021 PMID 33540185

25）Calculli A, et al：Parkinson disease following COVID-19；Report of six cases. Eur J Neurol 30：1272-1280, 2023 PMID 36807419

26）Jankovic J, Tan EK：Parkinson's disease；Etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 91：795-808, 2020 PMID 32576618

27）Piscitelli D, et al：Functional movement disorders in a patient with COVID-19. Neurol Sci 41：2343-2344, 2020 PMID 32661885

28）Shishorin R, et al：The onset of functional movement disorders after COVID-19；A case series. Indian J Psychiatry 64：529-532, 2022 PMID 36458078

29）Roper LS, et al：How to use the entrainment test in the diagnosis of functional tremor. Pract Neurol 13：396-398, 2013 PMID 23803954

30）Korres G, et al：The prevalence of dizziness and vertigo in COVID-19 patients；A systematic review. Brain Sci 12：948, 2022 PMID 35884754

31）Mizrahi B, et al：Long covid outcomes at one year after mild SARS-CoV-2 infection；Nationwide cohort study. BMJ 380：e072529, 2023 PMID 36631153

32）Kitsos D, et al：IL-6 serum levels in COVID-19 patients with vertigo. Cureus 15：e35042, 2023 PMID 36942191

33）Viola P, et al：Tinnitus and equilibrium disorders in COVID-19 patients；Preliminary results. Eur Arch Otorhinolaryngol 278：3725-3730, 2021 PMID 33095432

34）Ahmed M, et al：Neuro-imaging manifestations of COVID-19；Predilection for PICA infarcts. IDCases 24：e01131, 2021 PMID 33898251

35）Zaubitzer L, et al：The effects of COVID-19 on the vestibular system. Front Neurol 14：1134540, 2023 PMID 36970515

36）Ciorba A, et al：Don't forget ototoxicity during the SARS-CoV-2（Covid-19）pandemic! Int J Immunopathol Pharmacol 34：2058738420941754, 2020 PMID 32649262

37）Tan M, et al：Effects of Covid-19 on the audio-vestibular system. Am J Otolaryngol 43：103173, 2022 PMID 34392022

38）Zaubitzer L, et al：The effects of COVID-19 on the vestibular system. Front Neurol 14：1134540, 2023 PMID 36970515

39）Chen Q, et al：Clinical characteristics of 145 patients with corona virus disease 2019（COVID-19）in Taizhou, Zhejiang, China. Infection 48：543-551, 2020 PMID 32342479